107. 若年性特発性関節炎 Juvenile idiopathic arthritis Clinical trials / Disease details
臨床試験数 : 447 / 薬物数 : 297 - (DrugBank : 57) / 標的遺伝子数 : 52 - 標的パスウェイ数 : 146
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01015547 (ClinicalTrials.gov) | May 2003 | 17/11/2009 | Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis | Comparison of Anti-TNF Therapy Plus Methotrexate, Combination Therapy of DMARDs, and Methotrexate Alone in Very Early Polyarticular Juvenile Idiopathic Arthritis. A National Randomized Multicenter Clinical Trial. | Juvenile Idiopathic Arthritis | Drug: Infliximab plus methotrexate;Drug: Combination of DMARDs;Drug: Methotrexate alone | Helsinki University Central Hospital | Foundation for Paediatric Research, Finland;Päivikki and Sakari Sohlberg Foundation, Finland;Rheumatism Foundation Hospital;Scandinavian Rheumatology Research Foundation;Paijat-Hame Hospital District | Completed | 4 Years | 15 Years | Both | 60 | Phase 3 | Finland |